Regulatory T cells and plasmacytoid dendritic cells contribute to the immune escape of papillary thyroid cancer coexisting with multinodular non-toxic goiter

Endocrine

Volumn 44, Issue 1, 2013, Pages 172-181

  Yu, Hang ^a   Huang, Xiaomei ^a   Liu, Xiaosun ^a   Jin, Hailong ^a   Zhang, Ge'Er ^a   Zhang, Qing ^a   Yu, Jiren ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Multinodular non toxic goiter; Papillary thyroid cancer; Plasmacytoid dendritic cell; Regulatory T cell; Tumor escape

Indexed keywords

INTERLEUKIN 10; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; BLOOD SAMPLING; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; FOXP3+ REGULATORY T LYMPHOCYTE; HUMAN; HUMAN CELL; HUMAN TISSUE; ICOS+ FOXP3+ REGULATORY T LYMPHOCYTE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE DIFFERENTIATION; MALE; NODULAR GOITER; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; THYROID CARCINOMA; TUMOR ESCAPE;

ADULT; CARCINOMA; CASE-CONTROL STUDIES; CD4-POSITIVE T-LYMPHOCYTES; DENDRITIC CELLS; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GOITER, NODULAR; HUMANS; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; T-LYMPHOCYTES, REGULATORY; THYROID NEOPLASMS; TUMOR ESCAPE;

EID: 84881150970     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-012-9853-2     Document Type: Article

References (43)

1. - symporter (NIS) in a large sampling of thyroid cancer cases. J. Clin. Endocrinol. Metab. 86, 2697-2700 (2001)
2. F. Pacini, Changing natural history of differentiated thyroid cancer. Endocrine 42(2), 229-230 (2012)
3. L. Wartofsky, Increasing world incidence of thyroid cancer: increased detection or higher radiation exposure. Hormones (Athens) 9(2), 103-108 (2010)
4. L. Davies, H.G. Welch, Increasing incidence of thyroid cancer in the United States. 1973-2002. JAMA 295, 2164-2167 (2006)
5. L. Pagano, M. Caputo, M.T. Samà, V. Garbaccio, M. Zavattaro, M.G. Mauri, F. Prodam, P. Marzullo, R. Boldorini, G. Valente, G. Aimaretti, Clinical-pathological changes in differentiated thyroid cancer (DTC) over time (1997-2010): data from the University Hospital "Maggiore della Carità" in Novara. Endocrine 42, 382-390 (2012)
6. B.A. Kilfoy, T. Zheng, T.R. Holford et al., International patterns and trends in thyroid cancer incidence, 1973-2002. Cancer Causes Control 20(5), 525-531 (2009)
7. D.S. McLeod, D.S. Cooper, The incidence and prevalence of thyroid autoimmunity. Endocrine 42(2), 252-265 (2012)
8. M.R. Pelizzo, P. Bernante, A. Toniato, A. Fassina, Frequency of thyroid carcinoma in a recent series of 539 consecutive thyroidectomies for multinodular goiter. Tumori 83, 653-655 (1997)
9. I. Sachmechi, E. Miller, R. Varatharajah, A. Chernys, Z. Carroll, E. Kissin, Thyroid carcinoma in single cold nodules and in cold nodules of multinodular goiters. Endocr. Pract. 6, 5-7 (2000)
10. J. Modi, A. Patel, R. Terrell, R.M. Tuttle, G.L. Francis, Papillary thyroid carcinomas from young adults and children contain a mixture of lymphocytes. J. Clin. Endocrinol. Metab. 88, 4418-4425 (2003)
11. S. Gupta, A. Patel, A. Folstad, C. Fenton, C.A. Dinauer, R.M. Tuttle, R. Conran, G.L. Francis, Infiltration of differentiated thyroid carcinoma by proliferating lymphocytes is associated with improved disease-free survival for children and young adults. J. Clin. Endocrinol. Metab. 86, 1346-1354 (2001)
12. S. Matsubayashi, K. Kawai, Y. Matsumoto, T. Mukuta, T. Morita, K. Hirai, F. Matsuzuka, K. Kakudoh, K. Kuma, H. Tamai, The correlation between papillary thyroid carcinoma and lymphocytic infiltration in the thyroid gland. J. Clin. Endocrinol. Metab. 80, 3421-3424 (1995)
13. + regulatory T cell frequency correlate with more aggressive papillary thyroid cancer. J. Clin. Endocrinol. Metab. 95(5), 2325-2333 (2010)
14. F. Gogali, G. Paterakis, G.Z. Rassidakis, G. Kaltsas, C.I. Liakou, P. Gousis, E. Neonakis, M.N. Manoussakis, C. Liapi, Phenotypical analysis of lymphocytes with suppressive and regulatory properties (Tregs) and NK cells in the papillary carcinoma of thyroid. J. Clin. Endocrinol. Metab. 97(5), 1474-1482 (2012)
15. G.J. Bates, S.B. Fox, C. Han, R.D. Leek, J.F. Garcia, A.L. Harris, A.H. Banham, Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse. J. Clin. Oncol. 24, 5373-5380 (2006)
16. + T cell impairment and poor survival in hepatocellular carcinoma patients. Gastroenterology 132, 2328-2339 (2007)
17. + regulatory T cells increases during the progression of pancreatic ductal adenocarcinoma and its premalignant lesions. Clin. Cancer Res. 12, 5423-5434 (2006)
18. X.L. Yuan, L. Chen, M.X. Li, P. Dong, J. Xue, J. Wang, T.T. Zhang, X.A. Wang, F.M. Zhang, H.L. Ge, L.S. Shen, D. Xu, Elevated expression of Foxp3 in tumor-infiltrating Treg cells suppresses T-cell proliferation and contributes to gastric cancer progression in a COX-2-dependent manner. Clin. Immunol. 134, 277-288 (2010)
19. + regulatory T cells in human thymus and periphery. Immunity 28, 870-880 (2008)
20. K. McKenna, A.S. Beignon, N. Bhardwaj, Plasmacytoid dendritic cells: linking innate and adaptive immunity. J. Virol. 79, 17-27 (2005)
21. Y.J. Liu, Dendritic cell subsets and lineages, and their functions in innate and adaptive immunity. Cell 106, 259-262 (2001)
22. J. Tel, A.J. Lambeck, L.J. Cruz, P.J. Tacken, I.J. de Vries, C.G. Figdor, Human plasmacytoid dendritic cells phagocytose, process, and present exogenous particulate antigen. J. Immunol. 184, 4276-4283 (2010)
23. G. Gerlini, C. Urso, G. Mariotti, P. Di Gennaro, D. Palli, P. Brandani, A. Salvadori, N. Pimpinelli, U.M. Reali, L. Borgognoni, Plasmacytoid dendritic cells represent a major dendritic cell subset in sentinel lymph nodes of melanoma patients and accumulate in metastatic nodes. Clin. Immunol. 125, 184-193 (2007)
24. E. Hartmann, B. Wollenberg, S. Rothenfusser, M. Wagner, D. Wellisch, B. Mack, T. Giese, O. Gires, S. Endres, G. Hartmann, Identification and functional analysis of tumor-infiltrating plasmacytoid dendritic cells in head and neck cancer. Cancer Res. 63, 6478-6487 (2003)
25. I. Treilleux, J.Y. Blay, N. Bendriss-Vermare, I. Ray-Coquard, T. Bachelot, J.P. Guastalla, A. Bremond, S. Goddard, J.J. Pin, C. Barthelemy-Dubois, S. Lebecque, Dendritic cell infiltration and prognosis of early stage breast cancer. Clin. Cancer Res. 10, 7466-7474 (2004)
26. S.I. Labidi-Galy, V. Sisirak, P. Meeus, M. Gobert, I. Treilleux, A. Bajard, J.D. Combes, J. Faget, F. Mithieux, A. Cassignol, O. Tredan, I. Durand, C. Ménétrier-Caux, C. Caux, J.Y. Blay, I. Ray-Coquard, N. Bendriss-Vermare, Quantitative and functional alterations of plasmacytoid dendritic cells contribute to immune tolerance in ovarian cancer. Cancer Res. 71(16), 5423-5434 (2011)
27. T. Ito, M. Yang, Y.H. Wang, R. Lande, J. Gregorio, O.A. Perng, X.F. Qin, Y.J. Liu, M. Gilliet, Plasmacytoid dendritic cells prime IL-10-producing T regulatory cells by inducible costimulator ligand. J. Exp. Med. 204, 105-115 (2007)
28. American Joint Committee on Cancer, Thyroid, AJCC Cancer Staging Handbook, 6th edn. (Springer, New York, 2002), pp. 89-98
29. + T regulatory cells. Nat. Immunol. 4, 337-342 (2003)
30. J.D. Fontenot, J.P. Rasmussen, L.M. Williams, J.L. Dooley, A.G. Farr, A.Y. Rudensky, Regulatory T cell lineage specification by the forkhead transcription factor Foxp3. Immunity 22, 329-341 (2005)
31. T.J. Curiel, G. Coukos, L. Zou, X. Alvarez, P. Cheng, P. Mottram, M. Evdemon-Hogan, J.R. Conejo-Garcia, L. Zhang, M. Burow, Y. Zhu, S. Wei, I. Kryczek, B. Daniel, A. Gordon, L. Myers, A. Lackner, M.L. Disis, K.L. Knutson, L. Chen, W. Zou, Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat. Med. 10, 942-949 (2004)
32. C. Conrad, J. Gregorio, Y.H. Wang, T. Ito, S. Meller, S. Hanabuchi, S. Anderson, N. Atkinson, P.T. Ramirez, Y.J. Liu, R. Freedman, M. Gilliet, Plasmacytoid dendritic cells promote immunosuppression in ovarian cancer via ICOS costimulation of Foxp3 + T-regulatory cells. Cancer Res. 72(20), 5240-5249 (2012)
33. S. Schroder, W. Schwartz, W. Rehpenning, T. Loning, Bocker W Dendritic/Langerhans cells and prognosis in patients with papillary thyroid carcinomas. Am. J. Clin. Pathol. 89, 295-300 (1988)
34. + dendritic interstitial cells in thyroid lesions. Endocr Pathol 13(2), 111-115 (2002)
35. E. Gehrie, W. Van der Touw, J.S. Bromberg, J.C. Ochando, Plasmacytoid dendritic cells in tolerance. Methods Mol. Biol. 677, 127-147 (2011)
36. I. Treilleux, J.Y. Blay, N. Bendriss-Vermare, I. Ray-Coquard, T. Bachelot, J.P. Guastalla, A. Bremond, S. Goddard, J.J. Pin, C. Barthelemy-Dubois, S. Lebecque, Dendritic cell infiltration and prognosis of early stage breast cancer. Clin. Cancer Res. 10, 7466-7474 (2004)
37. W. Vermi, R. Bonecchi, F. Facchetti, D. Bianchi, S. Sozzani, S. Festa, A. Berenzi, M. Cella, M. Colonna, Recruitment of immature plasmacytoid dendritic cells (plasmacytoid monocytes) and myeloid dendritic cells in primary cutaneous melanomas. J. Pathol. 200, 255-268 (2003)
38. M.V. Dhodapkar, R.M. Steinman, J. Krasovsky, C. Munz, N. Bhardwaj, Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells. J. Exp. Med. 193, 233-238 (2001)
39. + Tr cells. Blood 105, 1162-1169 (2005)
40. D.H. Munn, A.L. Mellor, Indoleamine 2,3-dioxygenase and tumor-induced tolerance. J. Clin. Invest. 117, 1147-1154 (2007)
41. W. Chen, X. Liang, A.J. Peterson, D.H. Munn, B.R. Blazar, The indoleamine 2,3-dioxygenase pathway is essential for human plasmacytoid dendritic cell-induced adaptive T regulatory cell generation. J. Immunol. 181(8), 5396-5404 (2008)
42. M.D. Sharma, B. Baban, P. Chandler, D.Y. Hou, N. Singh, H. Yagita, M. Azuma, B.R. Blazar, A.L. Mellor, D.H. Munn, Plasmacytoid dendritic cells from mouse tumor draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase. J. Clin. Invest. 117, 2570-2582 (2007)
43. A. Stift, M. Sachet, R. Yagubian, C. Bittermann, P. Dubsky, C. Brostjan, R. Pfragner, B. Niederle, R. Jakesz, M. Gnant, J. Friedl, Dendritic cell vaccination in medullary thyroid carcinoma. Clin. Cancer Res. 10, 2944-2953 (2004)